{"id":"https://openalex.org/W990979913","doi":null,"title":"Inhibidores de BCR-ABL como un abordaje molecular de la leucemia mieloide cr\u00f3nica.","display_name":"Inhibidores de BCR-ABL como un abordaje molecular de la leucemia mieloide cr\u00f3nica.","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W990979913","mag":"990979913"},"language":"es","primary_location":{"id":"pmh:oai:digital.csic.es:10261/6271","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/6271","pdf_url":"http://hdl.handle.net/10261/6271","source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Art\u00edculo"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10261/6271","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073028672","display_name":"Manuel S\u00e1nchez\u2010Mart\u00edn","orcid":"https://orcid.org/0000-0001-8370-1336","observed_orcids":["https://orcid.org/0000-0001-8370-1336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuel S\u00e1nchez-Mart\u0131\u0301n","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8370-1336","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034607488","display_name":"Isidro S\u00e1nchez Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isidro S\u00e1nchez Garc\u00eda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/philadelphia-chromosome","display_name":"Philadelphia chromosome","score":0.9319999814033508},{"id":"https://openalex.org/keywords/bcr-abl-fusion","display_name":"BCR-ABL fusion gene","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.7960000038146973},{"id":"https://openalex.org/keywords/bcr-abl-oncogene","display_name":"BCR-ABL oncogene","score":0.5},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6129999756813049},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.6190000176429749},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9309999942779541},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.8820000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4707406461238861}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digital.csic.es:10261/6271","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/6271","pdf_url":"http://hdl.handle.net/10261/6271","source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Art\u00edculo"},{"id":"mag:990979913","doi":null,"is_oa":false,"landing_page_url":"http://digital.csic.es/bitstream/10261/6271/1/2003-Rev.%20Oncol.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:digital.csic.es:10261/6271","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/6271","pdf_url":"http://hdl.handle.net/10261/6271","source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Art\u00edculo"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W990979913.pdf","grobid_xml":"https://content.openalex.org/works/W990979913.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W57149238","https://openalex.org/W111932728","https://openalex.org/W120419820","https://openalex.org/W1510546584","https://openalex.org/W1520493856","https://openalex.org/W1537640166","https://openalex.org/W1614759083","https://openalex.org/W1972804480","https://openalex.org/W1997554349","https://openalex.org/W1998593414","https://openalex.org/W1999614615","https://openalex.org/W2006518962","https://openalex.org/W2011474502","https://openalex.org/W2016086822","https://openalex.org/W2017412420","https://openalex.org/W2018075615","https://openalex.org/W2019616754","https://openalex.org/W2034283748","https://openalex.org/W2034892057","https://openalex.org/W2040396943","https://openalex.org/W2076372887","https://openalex.org/W2089483984","https://openalex.org/W2097822594","https://openalex.org/W2107755271","https://openalex.org/W2109043126","https://openalex.org/W2112127173","https://openalex.org/W2149393207","https://openalex.org/W2151818038","https://openalex.org/W2171620774","https://openalex.org/W2312804644","https://openalex.org/W2313786846","https://openalex.org/W2324850882","https://openalex.org/W2486983515","https://openalex.org/W2608167493"],"related_works":["https://openalex.org/W1674790489","https://openalex.org/W2968863169","https://openalex.org/W2022731567","https://openalex.org/W4415717841","https://openalex.org/W6920550181","https://openalex.org/W3185466888","https://openalex.org/W4299697464","https://openalex.org/W1484360057","https://openalex.org/W7001173137","https://openalex.org/W1944173164"],"abstract_inverted_index":{"zando":[0],"como":[1,107,619],"modelo":[2],"el":[3,15,126,200,205,216,291,328,364,396,478,511,545,582,609],"producto":[4],"g\u00e9nico":[5],"de":[6,17,47,51,59,82,90,98,101,104,128,150,176,179,193,202,208,263,293,304,306,309,420,452,460,490,505,513,520,533,548,573,584,587,612,617,623],"la":[7,11,32,41,83,99,137,141,148,151,158,166,198,222,268,272,315,356,381,400,443,458,472,488,518,539,578,624],"anomal\u00eda":[8,224],"asociada":[9,36,164],"a":[10,37,140,165,191,355,391,404,411,428,449,487,595],"leucemia":[12,42,180,625],"mieloide":[13,43,626],"cr\u00f3nica,":[14],"gen":[16,206,247],"fusi\u00f3n":[18,129,138,316],"BCR-ABL.":[19],"BCR-ABL":[20,230,233,244,317,618],"Y":[21,245],"LEUCEMIA":[22],"MIELOIDE":[23],"CR\u00d3NICAEn":[24],"1959":[25],"Peter":[26],"Nowel":[27],"y":[28,94,96,124,213,232,241,259,286,399,418,492,524,531,576],"David":[29,331],"Hungerford":[30],"identificaron":[31],"primera":[33,382],"alteraci\u00f3n":[34,465],"cromos\u00f3mica":[35],"una":[38,114,254,276,385,526],"enfermedad":[39],"maligna,":[40],"cr\u00f3nica":[44,627],"(LMC).Las":[45],"metafases":[46],"estos":[48,209,353],"pacientes":[49,177,185,210],"contaban":[50],"manera":[52],"recurrente":[53],"con":[54,239,256,265,279,311,517],"un":[55,156,322,421,436,570,620],"cromosoma":[56,66,161],"m\u00e1s":[57],"peque\u00f1o":[58],"lo":[60,194,220,498],"normal":[61],"al":[62,296,469],"que":[63,76,136,142,195,235,297,313,347,363,384,403,430,441,485,557],"se":[64,110,168,236,287,361,409,480],"llam\u00f3":[65],"Filadelfia":[67,162],"3":[68],".Doce":[69],"a\u00f1os":[70,345],"despu\u00e9s,":[71],"Janet":[72],"D.":[73],"Rowley":[74],"demostr\u00f3":[75],"este":[77,105,170,603,606],"marcador":[78,172],"cromos\u00f3mico":[79],"era":[80,145,211],"consecuencia":[81],"translocaci\u00f3n":[84,123,252],"rec\u00edproca":[85],"entre":[86],"los":[87,91,118,461,552],"brazos":[88],"largos":[89],"cromosomas":[92],"9":[93],"22,":[95],"no":[97,433,521],"p\u00e9rdida":[100],"material":[102,372],"gen\u00e9tico":[103],"\u00faltimo,":[106],"hasta":[108,116,346],"entonces":[109],"cre\u00eda":[111],"4":[112],"(fig.1).Pasar\u00eda":[113],"d\u00e9cada":[115],"identificar":[117],"genes":[119,462],"implicados":[120],"en":[121,134,155,173,197,204,215,250,267,271,290,337,348,369,414,474,483,510,538,551,563,608],"esta":[122,251,299,389],"clonar":[125],"mARN":[127],"5,6":[130],".Estudios":[131],"posteriores":[132],"pusieron":[133],"evidencia":[135],"BCR-ABL,":[139],"nos":[143],"referimos,":[144],"esencial":[146],"para":[147,275,320,581],"g\u00e9nesis":[149],"LMC":[152,240,269],"7":[153,301],"(fig.2).Aunque":[154],"principio":[157],"presencia":[159],"del":[160,366,371,374,445],"estaba":[163,368],"LMC,":[167,199],"encontr\u00f3":[169],"mismo":[171],"algunos":[174],"linfoblastos":[175],"afectos":[178],"aguda":[181],"linfobl\u00e1stica":[182],"(LAL),":[183],"generalmente":[184],"adultos":[186],"2":[187,601],";":[188],"sin":[189,340,438],"embargo,":[190,341],"diferencia":[192],"sucede":[196],"punto":[201],"ruptura":[203],"BCR":[207,264],"diferente":[212],"suced\u00eda":[214],"primer":[217],"intr\u00f3n":[218],"(fig.3).Por":[219],"tanto,":[221,569],"misma":[223],"citogen\u00e9tica":[225],"produce":[226],"dos":[227,379],"oncogenes":[228],"diferentes,":[229],"p190":[231],"p210,":[234],"asocian":[237],"espec\u00edficamente":[238],"LAL,":[242],"respectivamente.":[243],"TUMOROG\u00c9NESISEl":[246],"ABL":[248,266],"implicado":[249],"codifica":[253],"prote\u00edna":[255,277],"actividad":[257,280,283],"tirosinquinasa":[258,281],"las":[260,392,406,534,564,591],"fusiones":[261],"g\u00e9nicas":[262,408,536],"o":[270,503,589],"LAL":[273],"codifican":[274,314],"quim\u00e9rica":[278],"constitutiva.Esta":[282],"es":[284,318,383,402,556],"crucial":[285],"considera":[288],"indispensable":[289],"mecanismo":[292],"transformaci\u00f3n":[294,357,540],"celular":[295,541],"induce":[298],"oncoprote\u00edna":[300],".La":[302],"infecci\u00f3n":[303],"c\u00e9lulas":[305,338,393,565],"m\u00e9dula":[307],"\u00f3sea":[308],"rat\u00f3n":[310],"retrovirus":[312],"suficiente":[319],"causar":[321],"s\u00edndrome":[323],"mieloproliferativo":[324],"INTRODUCCI\u00d3N":[325],"En":[326],"1890":[327],"bi\u00f3logo":[329],"alem\u00e1n":[330],"von":[332],"Hansemann":[333],"observ\u00f3":[334],"aberraciones":[335,432,596],"cromos\u00f3micas":[336,455,597],"tumorales;":[339],"pasar\u00edan":[342],"casi":[343],"25":[344],"1914":[349],"Theodor":[350],"Boveri":[351],"artribuyera":[352],"hallazgos":[354],"maligna":[358],"1":[359],".Pronto":[360],"sospech\u00f3":[362],"origen":[365],"c\u00e1ncer":[367,479],"alteraciones":[370,407,454,535,559],"hereditario,":[373],"ADN":[375,491],"(alteraciones":[376],"g\u00e9nicas),":[377],"por":[378,497,568],"razones:":[380],"c\u00e9lula":[386],"tumoral":[387,423],"pasaba":[388],"propiedad":[390],"hijas":[394],"(heredaban":[395],"fenotipo":[397,422],"tumoral)":[398],"segunda":[401],"veces":[405],"deb\u00edan":[410,434],"anomal\u00edas":[412],"cromos\u00f3micas,":[413],"muchos":[415],"casos,":[416],"recurrentes":[417,598],"espec\u00edficas":[419],"dado.Este":[424],"\u00faltimo":[425],"dato":[426],"llev\u00f3":[427],"pensar":[429],"esas":[431],"ser":[435,522],"epifen\u00f3meno":[437],"m\u00e1s,":[439],"sino":[440],"eran":[442],"causa":[444],"proceso":[446],"neoformativo.La":[447],"caracterizaci\u00f3n":[448,529],"nivel":[450],"molecular":[451,530,622],"dichas":[453],"permiti\u00f3":[456],"posteriormente":[457],"identificaci\u00f3n":[459],"(protooncogenes)":[463],"cuya":[464],"estructural":[466],"(oncogenes)":[467],"lleva":[468],"c\u00e1ncer.Hasta":[470],"1980":[471],"investigaci\u00f3n":[473],"f\u00e1rmacos":[475,575],"terap\u00e9uticos":[476],"contra":[477],"focaliz\u00f3":[481],"exclusivamente":[482],"aquellos":[484],"afectaban":[486],"s\u00edntesis":[489],"ciclo":[493],"celular.Estos":[494],"agentes":[495,501],"son,":[496],"general,":[499],"antimetabolitos,":[500],"alquilantes":[502],"desestabilizadores":[504],"microt\u00fabulos.Aun":[506],"mostrada":[507],"su":[508],"eficacia":[509],"tratamiento":[512,583],"diferentes":[514],"neoplasias,":[515,585],"cuentan":[516],"desventaja":[519],"selectivos":[523],"mostrar":[525],"alta":[527],"toxicidad.La":[528],"funcional":[532],"implicadas":[537],"ha":[542],"cambiado":[543],"sobremanera":[544],"panorama":[546],"terap\u00e9utico":[547,611],"estas":[549,558],"enfermedades":[550],"\u00faltimos":[553],"a\u00f1os.La":[554],"raz\u00f3n":[555],"s\u00f3lo":[560],"est\u00e1n":[561,593],"presentes":[562],"tumorales":[566],"permitiendo,":[567],"dise\u00f1o":[571],"racional":[572],"nuevos":[574],"marcando":[577],"pauta":[579],"estrat\u00e9gica":[580],"especialmente":[586],"leucemias":[588],"sarcomas,":[590],"cuales":[592],"asociadas":[594],"bien":[599],"caracterizadas":[600],".En":[602],"cap\u00edtulo":[604],"revisaremos":[605],"cambio":[607],"desarrollo":[610],"mol\u00e9culas":[613],"antineopl\u00e1sicas":[614],"utili-":[615],"Inhibidores":[616],"abordaje":[621]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}